Yu‐Min Yeh

Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA Trial

Cristina Saura, Mafalda Oliveira, Yin‐Hsun Feng et al. · Journal of Clinical Oncology · 2020 · 609 citations · Full text

Medicine, Oncology, Pharmacology +15

Lenvatinib Plus Pembrolizumab Versus Standard of Care for Previously Treated Metastatic Colorectal Cancer: Final Analysis of the Randomized, Open-Label, Phase III LEAP-017 Study

Akihito Kawazoe, Rui‐Hua Xu, Pilar García‐Alfonso et al. · Journal of Clinical Oncology · 2024 · 77 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Large B cell lymphoma presenting initially in bone marrow, liver and spleen: an aggressive entity associated frequently with haemophagocytic syndrome

Yu‐Min Yeh, Kung‐Chao Chang, Yaping Chen et al. · Histopathology · 2010 · 39 citations

Medicine, Oncology, Pathology +16

CHK2 activation contributes to the development of oxaliplatin resistance in colorectal cancer

Chi–Che Hsieh, Sen-Huei Hsu, Chih‐Yu Lin et al. · British Journal of Cancer · 2022 · 34 citations · Full text

Medicine, Molecular Biology, Oncology +17

Low incidence of thromboembolism in relapsed/refractory myeloma patients treated with thalidomide without thromboprophylaxis in Taiwan

Shang‐Yin Wu, Yu‐Min Yeh, Yaping Chen et al. · Annals of Hematology · 2012 · 24 citations

Medicine, Hematology, Pharmacology +12